Jefferson Life Sciences
Overview
Investment firm specializing in life sciences.
Deals · 12mo
3
Links
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Draig Therapeutics | Jul 2026Participated | $65 MSeries B | |
FesariusTherapeutics | Jun 2026Led | $20 MSeries A | |
Juvena Therapeutics | Jan 2026Participated | $34 MSeries B | |
Character Biosciences | Mar 2025Participated | $93 MSeries B | |
Draig Therapeutics | Jul 2026Participated | $65 MSeries B | |
FesariusTherapeutics | Jun 2026Led | $20 MSeries A | |
Juvena Therapeutics | Jan 2026Participated | $34 MSeries B | |
Character Biosciences | Mar 2025Participated | $93 MSeries B |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series A | 1 | 0 |
| Series B | 0 | 3 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Mar '25 | 1 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 1 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 1 |
| Jul '26 | 1 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 4 |
| Marketing & Advertising | 1 |
| Manufacturing | 1 |
| Consumer & Lifestyle | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 0 |
| $10M-$25M | 1 |
| $25M-$50M | 1 |
| $50M-$100M | 2 |
| $100M-$250M | 0 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 3 |
| Europe | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| American Society of Plastic Surgeons | 1 |
| aMoon | 1 |
| Bausch & Lomb | 1 |
| Bison Ventures | 1 |
| British Business Bank | 1 |
| Catalio Capital Management | 1 |
| Deep Track Capital | 1 |
| Eli Lilly and Company | 1 |
| Innovation Endeavors | 1 |
| Janus Henderson Investors | 1 |
| Johnson & Johnson Innovation | 1 |
| KdT Ventures | 1 |
| Luma Group | 1 |
| Manta Ray Ventures | 1 |
| Marshall Wace | 1 |
| Mubadala Capital | 1 |
| New York Ventures | 1 |
| Section 32 | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 1 | 25% |
| Participating | 3 | 75% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 1 | 100% |
| Co-led | 0 | 0% |
Team
Chief Business Officer